Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. M. Brantley-Sieders
Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
Cancer Research
Cancer Research
Oncology
Related publications
Claudin-4 Controls the Receptor Tyrosine Kinase EphA2 Pro-Oncogenic Switch Through ?-Catenin
Cell Communication and Signaling
Biochemistry
Cell Biology
Molecular Biology
A Conditional Transmembrane Peptide Inhibits Cell Migration by Activation of the EphA2 Receptor Tyrosine Kinase
Biophysical Journal
Biophysics
Bruton’s Tyrosine Kinase Mediates FcγRIIa/Toll-Like Receptor–4 Receptor Crosstalk in Human Neutrophils
American Journal of Respiratory Cell and Molecular Biology
Respiratory Medicine
Pulmonary
Clinical Biochemistry
Cell Biology
Molecular Biology
Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
APOBEC3 Mediates Resistance to Oncolytic Viral Therapy
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Personalized Therapy of Tyrosine Kinase Inhibitors
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Tight Junction Protein Junctional Adhesion Molecule-A Regulates the Expression of Receptor Tyrosine Kinase EPHA2 in Triple-Negative Breast Cancer Cells
Clinical Oncology and Research
Expression of T-Darpp Mediates Trastuzumab Resistance in Breast Cancer Cells
Clinical Cancer Research
Cancer Research
Oncology
Receptor Tyrosine Kinase (RTK); VEGF-A
Science-Business eXchange
